| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.763 | 0.004 | 0.763 | Alpha adrenoreceptor antagonist | 0.331 0.013 CID_88638 | ||
| 0.761 | 0.003 | 0.761 | Alpha 1 adrenoreceptor antagonist | 0.28 0.012 CID_88638 | ||
| 0.735 | 0.003 | 0.735 | Alpha 1a adrenoreceptor antagonist | 0.254 0.012 CID_88638 | ||
| 0.709 | 0.003 | 0.709 | Alpha 1b adrenoreceptor antagonist | 0.25 0.01 CID_88638 | ||
| 0.675 | 0.004 | 0.675 | Dopamine antagonist | 0.195 0.019 CID_88638 | ||
| 0.669 | 0.004 | 0.669 | Dopamine D2 antagonist | 0.181 0.019 CID_88638 | ||
| 0.657 | 0.004 | 0.657 | 5 Hydroxytryptamine 2 antagonist | 0.259 0.02 CID_88638 | ||
| 0.655 | 0.004 | 0.655 | Dopamine D4 antagonist | 0.108 0.024 CID_88638 | ||
| 0.65 | 0.019 | 0.65 | Analgesic | 0.47 0.058 CID_88638 | ||
| 0.628 | 0.007 | 0.628 | HERG channel blocker | 0.386 0.03 CID_88638 | ||
| 0.623 | 0.003 | 0.623 | Alpha 1d adrenoreceptor antagonist | 0.146 0.015 CID_88638 | ||
| 0.619 | 0.005 | 0.619 | 5 Hydroxytryptamine antagonist | 0.339 0.015 CID_88638 | ||
| 0.605 | 0.004 | 0.605 | Nav1.2 sodium channel blocker | 0.193 0.037 CID_88638 | ||
| 0.591 | 0.004 | 0.591 | 5 Hydroxytryptamine 2B antagonist | 0.296 0.015 CID_88638 | ||
| 0.582 | 0.004 | 0.582 | 5 Hydroxytryptamine 2A antagonist | 0.181 0.022 CID_88638 | ||
| 0.594 | 0.017 | 0.594 | Vasodilator, peripheral | 0.522 0.024 CID_88638 | ||
| 0.578 | 0.004 | 0.578 | Antihistaminic | 0.176 0.025 CID_88638 | ||
| 0.575 | 0.004 | 0.575 | Histamine antagonist | 0.167 0.025 CID_88638 | ||
| 0.569 | 0.004 | 0.569 | 5 Hydroxytryptamine 2C antagonist | 0.221 0.015 CID_88638 | ||
| 0.569 | 0.009 | 0.569 | Potassium channel (Voltage-sensitive) blocker | 0.307 0.047 CID_88638 | ||
| 0.544 | 0.004 | 0.544 | Histamine H1 receptor antagonist | 0.12 0.032 CID_88638 | ||
| 0.536 | 0.003 | 0.536 | Alpha 1 adrenoreceptor agonist | 0.139 0.01 CID_88638 | ||
| 0.516 | 0.004 | 0.516 | 5 Hydroxytryptamine 7 antagonist | 0.266 0.007 CID_88638 | ||
| 0.503 | 0.009 | 0.503 | Sigma receptor agonist | |||
| 0.485 | 0.004 | 0.485 | 5 Hydroxytryptamine 1E antagonist | 0.408 0.005 CID_88638 | ||
| 0.485 | 0.004 | 0.485 | Nav1.1 sodium channel blocker | 0.329 0.006 CID_88638 | ||
| 0.481 | 0.004 | 0.481 | Dopamine D3 antagonist | 0.135 0.017 CID_88638 | ||
| 0.475 | 0.003 | 0.475 | Ca(v)3.3 blocker | |||
| 0.466 | 0.015 | 0.466 | Anticonvulsant | 0.293 0.042 CID_88638 | ||
| 0.45 | 0.005 | 0.45 | 5 Hydroxytryptamine 1A antagonist | 0.186 0.016 CID_88638 | ||
| 0.44 | 0.004 | 0.44 | Dopamine D1 antagonist | 0.13 0.018 CID_88638 | ||
| 0.441 | 0.005 | 0.441 | 5 Hydroxytryptamine 1 antagonist | 0.175 0.019 CID_88638 | ||
| 0.439 | 0.005 | 0.439 | Acetylcholine M1 receptor antagonist | 0.345 0.009 CID_88638 | ||
| 0.42 | 0.003 | 0.42 | 5 Hydroxytryptamine 5A antagonist | 0.093 0.018 CID_88638 | ||
| 0.412 | 0.003 | 0.412 | Dopamine D5 antagonist | 0.087 0.011 CID_88638 | ||
| 0.413 | 0.004 | 0.413 | Alpha 2c adrenoreceptor antagonist | 0.213 0.015 CID_88638 | ||
| 0.394 | 0.002 | 0.424 | 5 Hydroxytryptamine 3A agonist | 0.424 0.002 CID_88638 | CID_88638 | |
| 0.395 | 0.004 | 0.633 | Acetylcholine agonist | 0.633 0.003 CID_88638 | CID_88638 | |
| 0.389 | 0.004 | 0.389 | Ca(v)2.2 blocker | |||
| 0.385 | 0.005 | 0.385 | Calcium channel (voltage-sensitive) blocker | |||
| 0.385 | 0.005 | 0.385 | Calcium channel blocker | |||
| 0.392 | 0.024 | 0.392 | Potassium channel blocker | 0.157 0.129 CID_88638 | ||
| 0.371 | 0.005 | 0.371 | Acetylcholine muscarinic antagonist | 0.231 0.018 CID_88638 | ||
| 0.358 | 0.006 | 0.358 | Alpha 2b adrenoreceptor antagonist | 0.214 0.021 CID_88638 | ||
| 0.353 | 0.003 | 0.353 | Calcium channel T-type blocker | 0.053 0.05 CID_88638 | ||
| 0.348 | 0.003 | 0.513 | Acetylcholine muscarinic agonist | 0.513 0.002 CID_88638 | CID_88638 | |
| 0.347 | 0.004 | 0.347 | Alpha adrenoreceptor agonist | 0.18 0.011 CID_88638 | ||
| 0.348 | 0.006 | 0.348 | Nav1.3 sodium channel blocker | |||
| 0.344 | 0.004 | 0.344 | 5 Hydroxytryptamine 5 antagonist | 0.076 0.022 CID_88638 | ||
| 0.341 | 0.003 | 0.488 | Nociceptin (N/OFQ) receptor antagonist | 0.488 0.003 CID_88638 | CID_88638 | |
| 0.378 | 0.045 | 0.378 | Spasmolytic | 0.206 0.114 CID_88638 | ||
| 0.333 | 0.004 | 0.333 | Acetylcholine M4 receptor antagonist | 0.193 0.006 CID_88638 | ||
| 0.33 | 0.005 | 0.33 | Neuropeptide Y antagonist | 0.116 0.031 CID_88638 | ||
| 0.329 | 0.012 | 0.329 | Cholinergic antagonist | 0.245 0.022 CID_88638 | ||
| 0.321 | 0.012 | 0.321 | Acetylcholine antagonist | 0.239 0.022 CID_88638 | ||
| 0.309 | 0.013 | 0.309 | Antiadrenergic | 0.204 0.024 CID_88638 | ||
| 0.303 | 0.013 | 0.303 | Adrenaline antagonist | 0.201 0.023 CID_88638 | ||
| 0.277 | 0.004 | 0.504 | Acetylcholine M1 receptor agonist | 0.504 0.002 CID_88638 | CID_88638 | |
| 0.29 | 0.02 | 0.51 | Cholinergic | 0.51 0.005 CID_88638 | CID_88638 | |
| 0.272 | 0.01 | 0.272 | Alpha 2 adrenoreceptor antagonist | 0.205 0.017 CID_88638 | ||
| 0.324 | 0.07 | 0.324 | Calcium channel activator | 0.22 0.184 CID_88638 | ||
| 0.258 | 0.009 | 0.258 | NMDA receptor antagonist | 0.089 0.055 CID_88638 | ||
| 0.312 | 0.063 | 0.741 | Aldehyde oxidase inhibitor | 0.741 0.006 CID_88638 | CID_88638 | |
| 0.247 | 0.003 | 0.445 | Acetylcholine M3 receptor agonist | 0.445 0.002 CID_88638 | CID_88638 | |
| 0.247 | 0.004 | 0.247 | Acetylcholine M5 receptor antagonist | 0.127 0.011 CID_88638 | ||
| 0.229 | 0.005 | 0.229 | Calcium channel L-type blocker | |||
| 0.219 | 0.002 | 0.279 | Acetylcholine M5 receptor agonist | 0.279 0.002 CID_88638 | CID_88638 | |
| 0.21 | 0.001 | 0.21 | Phospholipase D inhibitor | 0.204 0.001 CID_88638 | ||
| 0.205 | 0.006 | 0.205 | Acetylcholine M3 receptor antagonist | 0.089 0.022 CID_88638 | ||
| 0.251 | 0.063 | 0.282 | Cyclic AMP phosphodiesterase inhibitor | 0.282 0.049 CID_88638 | CID_88638 | |
| 0.184 | 0.004 | 0.411 | Acetylcholine M2 receptor agonist | 0.411 0.002 CID_88638 | CID_88638 | |
| 0.184 | 0.004 | 0.337 | 5 Hydroxytryptamine 3A antagonist | 0.337 0.003 CID_88638 | CID_88638 | |
| 0.193 | 0.018 | 0.193 | Calcium channel N-type blocker | |||
| 0.176 | 0.008 | 0.176 | Dopamine uptake inhibitor | |||
| 0.178 | 0.01 | 0.178 | 5 Hydroxytryptamine 1B antagonist | 0.128 0.016 CID_88638 | ||
| 0.184 | 0.022 | 0.184 | Chemokine receptor antagonist | 0.092 0.072 CID_88638 | ||
| 0.204 | 0.043 | 0.206 | Diuretic | 0.206 0.042 CID_88638 | CID_88638 | |
| 0.168 | 0.009 | 0.168 | Acetylcholine M2 receptor antagonist | 0.117 0.017 CID_88638 | ||
| 0.171 | 0.014 | 0.171 | CC chemokine receptor antagonist | |||
| 0.182 | 0.027 | 0.182 | Nav1.6 sodium channel blocker | |||
| 0.183 | 0.028 | 0.183 | Neuropeptide Y1 antagonist | 0.157 0.054 CID_88638 | ||
| 0.167 | 0.013 | 0.167 | 5 Hydroxytryptamine 1 agonist | 0.058 0.034 CID_88638 | ||
| 0.155 | 0.007 | 0.155 | Histamine H3 receptor antagonist | 0.055 0.024 CID_88638 | ||
| 0.236 | 0.092 | 0.236 | Cardiotonic | |||
| 0.164 | 0.022 | 0.209 | Opioid antagonist | 0.209 0.013 CID_88638 | CID_88638 | |
| 0.143 | 0.004 | 0.143 | CC chemokine 5 receptor agonist | 0.087 0.043 CID_88638 | ||
| 0.149 | 0.017 | 0.191 | 5 Hydroxytryptamine 1F antagonist | 0.191 0.011 CID_88638 | CID_88638 | |
| 0.22 | 0.089 | 0.22 | Vasodilator | 0.187 0.115 CID_88638 | ||
| 0.134 | 0.003 | 0.253 | Nociceptin (N/OFQ) receptor agonist | 0.253 0.002 CID_88638 | CID_88638 | |
| 0.148 | 0.017 | 0.175 | Opioid kappa receptor antagonist | 0.175 0.013 CID_88638 | CID_88638 | |
| 0.257 | 0.127 | 0.257 | Vasodilator, coronary | |||
| 0.219 | 0.09 | 0.222 | Neuropeptide Y2 antagonist | 0.222 0.085 CID_88638 | CID_88638 | |
| 0.132 | 0.003 | 0.256 | Calcitonin gene-related peptide 1 receptor antagonist | 0.256 0.002 CID_88638 | CID_88638 | |
| 0.14 | 0.011 | 0.14 | 5 Hydroxytryptamine 1A agonist | |||
| 0.152 | 0.033 | 0.174 | Interleukin 8 antagonist | 0.174 0.021 CID_88638 | CID_88638 | |
| 0.264 | 0.144 | 0.359 | Antiobesity | 0.359 0.083 CID_88638 | CID_88638 | |
| 0.124 | 0.005 | 0.124 | CC chemokine 5 receptor antagonist | |||
| 0.199 | 0.08 | 0.199 | Psychostimulant | 0.197 0.082 CID_88638 | ||
| 0.135 | 0.018 | 0.135 | 5 Hydroxytryptamine uptake inhibitor | 0.088 0.031 CID_88638 | ||
| 0.139 | 0.024 | 0.261 | 5 Hydroxytryptamine agonist | 0.261 0.01 CID_88638 | CID_88638 | |
| 0.139 | 0.025 | 0.163 | Alpha 2a adrenoreceptor antagonist | 0.163 0.02 CID_88638 | CID_88638 | |
| 0.122 | 0.008 | 0.285 | 5 Hydroxytryptamine 3 agonist | 0.285 0.003 CID_88638 | CID_88638 | |
| 0.111 | 0.004 | 0.291 | Acetylcholine M4 receptor agonist | 0.291 0.002 CID_88638 | CID_88638 | |
| 0.125 | 0.019 | 0.125 | Dopamine agonist | 0.113 0.022 CID_88638 | ||
| 0.12 | 0.017 | 0.12 | 5 Hydroxytryptamine 1D antagonist | 0.08 0.031 CID_88638 | ||
| 0.099 | 0.003 | 0.325 | Calcitonin gene-related peptide antagonist | 0.325 0.002 CID_88638 | CID_88638 | |
| 0.107 | 0.015 | 0.107 | Sigma receptor antagonist | |||
| 0.106 | 0.016 | 0.371 | 5 Hydroxytryptamine 3 antagonist | 0.371 0.004 CID_88638 | CID_88638 | |
| 0.301 | 0.212 | 0.433 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.433 0.073 CID_88638 | CID_88638 | |
| 0.115 | 0.026 | 0.142 | Opioid mu receptor antagonist | 0.142 0.019 CID_88638 | CID_88638 | |
| 0.105 | 0.018 | 0.236 | Toll-Like receptor 7 antagonist | 0.236 0.004 CID_88638 | CID_88638 | |
| 0.096 | 0.01 | 0.096 | CC chemokine 3 receptor antagonist | 0.044 0.027 CID_88638 | ||
| 0.101 | 0.018 | 0.101 | Adrenaline uptake inhibitor | 0.096 0.02 CID_88638 | ||
| 0.092 | 0.01 | 0.092 | Ca(v)3.2 blocker | |||
| 0.093 | 0.011 | 0.134 | Neurokinin 2 antagonist | 0.134 0.007 CID_88638 | CID_88638 | |
| 0.087 | 0.01 | 0.112 | 5 Hydroxytryptamine 4 antagonist | 0.112 0.005 CID_88638 | CID_88638 | |
| 0.082 | 0.007 | 0.218 | 5 Hydroxytryptamine 3B antagonist | 0.218 0.003 CID_88638 | CID_88638 | |
| 0.099 | 0.024 | 0.099 | Ca(v)3.1 blocker | |||
| 0.091 | 0.018 | 0.104 | 5 Hydroxytryptamine 6 antagonist | 0.104 0.014 CID_88638 | CID_88638 | |
| 0.102 | 0.029 | 0.136 | Nicotinic alpha4beta2 receptor antagonist | 0.136 0.011 CID_88638 | CID_88638 | |
| 0.089 | 0.017 | 0.089 | Dopamine D4 agonist | 0.065 0.024 CID_88638 | ||
| 0.078 | 0.009 | 0.117 | Sodium/calcium exchanger inhibitor | 0.117 0.005 CID_88638 | CID_88638 | |
| 0.174 | 0.106 | 0.174 | Neurotrophic factor enhancer | |||
| 0.072 | 0.005 | 0.072 | CC chemokine 1 receptor antagonist | |||
| 0.084 | 0.018 | 0.238 | Opioid agonist | 0.238 0.005 CID_88638 | CID_88638 | |
| 0.101 | 0.036 | 0.101 | Adrenaline agonist | 0.081 0.057 CID_88638 | ||
| 0.107 | 0.043 | 0.107 | Calcium antagonist | |||
| 0.118 | 0.057 | 0.118 | Nav1.5 sodium channel blocker | |||
| 0.066 | 0.004 | 0.066 | Glutamate (mGluR8) antagonist | |||
| 0.097 | 0.038 | 0.097 | Histamine H2 receptor antagonist | |||
| 0.127 | 0.068 | 0.127 | Glutamate receptor antagonist | |||
| 0.134 | 0.076 | 0.134 | Neurotrophic factor | |||
| 0.089 | 0.033 | 0.089 | Viral attachment inhibitor | 0.075 0.061 CID_88638 | ||
| 0.094 | 0.038 | 0.094 | Phosphodiesterase 11A inhibitor | 0.089 0.044 CID_88638 | ||
| 0.094 | 0.038 | 0.094 | Phosphodiesterase XI inhibitor | 0.089 0.044 CID_88638 | ||
| 0.074 | 0.019 | 0.074 | Dopamine transporter inhibitor | |||
| 0.139 | 0.084 | 0.139 | NOS3 expression enhancer | 0.119 0.118 CID_88638 | ||
| 0.128 | 0.074 | 0.333 | Toll-Like receptor antagonist | 0.333 0.005 CID_88638 | CID_88638 | |
| 0.137 | 0.085 | 0.137 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.082 | 0.03 | 0.082 | Potassium channel (Tandem pore domain) blocker | |||
| 0.072 | 0.019 | 0.109 | Neurokinin antagonist | 0.109 0.009 CID_88638 | CID_88638 | |
| 0.207 | 0.156 | 0.207 | Immunomodulator | 0.192 0.174 CID_88638 | ||
| 0.224 | 0.174 | 0.224 | Toll-Like receptor 7 agonist | |||
| 0.119 | 0.071 | 0.157 | MAP kinase 12 inhibitor | 0.157 0.038 CID_88638 | CID_88638 | |
| 0.055 | 0.009 | 0.055 | Sigma 2 receptor antagonist | 0.026 0.019 CID_88638 | ||
| 0.084 | 0.038 | 0.084 | Nav1.8 sodium channel blocker | |||
| 0.047 | 0.005 | 0.047 | Adenosine uptake inhibitor | 0.038 0.016 CID_88638 | ||
| 0.061 | 0.019 | 0.086 | Neurokinin 3 antagonist | 0.086 0.008 CID_88638 | CID_88638 | |
| 0.081 | 0.041 | 0.158 | Protein kinase B beta inhibitor | 0.158 0.007 CID_88638 | CID_88638 | |
| 0.22 | 0.179 | 0.22 | Toll-Like receptor agonist | |||
| 0.117 | 0.078 | 0.184 | DNA repair enzyme inhibitor | 0.184 0.012 CID_88638 | CID_88638 | |
| 0.164 | 0.125 | 0.353 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.353 0.024 CID_88638 | CID_88638 | |
| 0.055 | 0.016 | 0.093 | Neurokinin 1 antagonist | 0.093 0.007 CID_88638 | CID_88638 | |
| 0.108 | 0.069 | 0.137 | MAP kinase 13 inhibitor | 0.137 0.043 CID_88638 | CID_88638 | |
| 0.124 | 0.087 | 0.124 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.078 | 0.044 | 0.078 | Epoxide hydrolase inhibitor | |||
| 0.054 | 0.022 | 0.102 | CC chemokine 4 receptor antagonist | 0.102 0.004 CID_88638 | CID_88638 | |
| 0.079 | 0.048 | 0.208 | Protein kinase B gamma inhibitor | 0.208 0.007 CID_88638 | CID_88638 | |
| 0.059 | 0.028 | 0.059 | Chemokine receptor agonist | |||
| 0.088 | 0.057 | 0.088 | Histamine N-methyltransferase inhibitor | |||
| 0.048 | 0.018 | 0.056 | Substance P antagonist | 0.056 0.013 CID_88638 | CID_88638 | |
| 0.078 | 0.05 | 0.112 | Analgesic, opioid | 0.112 0.026 CID_88638 | CID_88638 | |
| 0.053 | 0.027 | 0.129 | Opioid mu receptor agonist | 0.129 0.009 CID_88638 | CID_88638 | |
| 0.029 | 0.005 | 0.136 | Somatostatin 2 agonist | 0.136 0.003 CID_88638 | CID_88638 | |
| 0.037 | 0.014 | 0.037 | Sigma 1 receptor antagonist | |||
| 0.083 | 0.06 | 0.083 | Myeloperoxidase inhibitor | |||
| 0.092 | 0.071 | 0.108 | Phosphodiesterase 6D inhibitor | 0.108 0.038 CID_88638 | CID_88638 | |
| 0.054 | 0.034 | 0.054 | Histamine agonist | |||
| 0.035 | 0.016 | 0.052 | 5 Hydroxytryptamine 1D agonist | 0.052 0.01 CID_88638 | CID_88638 | |
| 0.107 | 0.088 | 0.107 | Transcription factor STAT6 inhibitor | |||
| 0.112 | 0.094 | 0.112 | Sodium channel blocker | |||
| 0.047 | 0.029 | 0.051 | Dopamine D2 agonist | 0.051 0.026 CID_88638 | CID_88638 | |
| 0.19 | 0.172 | 0.229 | Nootropic | 0.229 0.126 CID_88638 | CID_88638 | |
| 0.027 | 0.011 | 0.038 | 5 Hydroxytryptamine 4 agonist | 0.038 0.004 CID_88638 | CID_88638 | |
| 0.18 | 0.167 | 0.18 | Transcription factor STAT inhibitor | |||
| 0.044 | 0.03 | 0.044 | Histamine H1 receptor agonist | 0.041 0.038 CID_88638 | ||
| 0.033 | 0.02 | 0.133 | Somatostatin agonist | 0.133 0.006 CID_88638 | CID_88638 | |
| 0.06 | 0.047 | 0.126 | Phosphodiesterase VII inhibitor | 0.126 0.005 CID_88638 | CID_88638 | |
| 0.044 | 0.033 | 0.099 | Poly(ADP-ribose) polymerase inhibitor | 0.099 0.008 CID_88638 | CID_88638 | |
| 0.043 | 0.032 | 0.043 | Glutamate (mGluR group III) antagonist | |||
| 0.05 | 0.04 | 0.085 | Phosphodiesterase 7A inhibitor | 0.085 0.005 CID_88638 | CID_88638 | |
| 0.05 | 0.04 | 0.05 | Melanin-concentrating hormone receptor 1 antagonist | |||
| 0.052 | 0.042 | 0.052 | CC chemokine 2 receptor antagonist | |||
| 0.06 | 0.051 | 0.06 | Beta 2 adrenoreceptor agonist | |||
| 0.087 | 0.079 | 0.087 | Alpha 2d adrenoreceptor antagonist | |||
| 0.046 | 0.038 | 0.07 | Histamine H4 receptor antagonist | 0.07 0.012 CID_88638 | CID_88638 | |
| 0.038 | 0.03 | 0.038 | Nicotinic acid receptor 1 agonist | |||
| 0.05 | 0.044 | 0.139 | GABA receptor antagonist | 0.139 0.01 CID_88638 | CID_88638 | |
| 0.017 | 0.012 | 0.017 | Kainate receptor 3 antagonist | |||
| 0.04 | 0.036 | 0.049 | DNA gyrase subunit A inhibitor | 0.049 0.018 CID_88638 | CID_88638 | |
| 0.047 | 0.045 | 0.172 | Toll-Like receptor 8 antagonist | 0.172 0.004 CID_88638 | CID_88638 | |
| 0.034 | 0.032 | 0.056 | ATM kinase inhibitor | 0.056 0.006 CID_88638 | CID_88638 | |
| 0.018 | 0.016 | 0.023 | Granulocyte colony stimulating factor receptor agonist | 0.023 0.005 CID_88638 | CID_88638 | |
| 0.052 | 0.051 | 0.052 | Cannabinoid CB1 receptor agonist | |||
| 0.079 | 0.078 | 0.127 | Phosphodiesterase I inhibitor | 0.127 0.024 CID_88638 | CID_88638 | |
| 0.036 | 0.039 | 0.048 | Thymidine kinase inhibitor | 0.048 0.02 CID_88638 | CID_88638 | |
| 0.062 | 0.066 | 0.087 | MDM2 inhibitor | 0.087 0.013 CID_88638 | CID_88638 | |
| 0.018 | 0.023 | 0.024 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.024 0.008 CID_88638 | CID_88638 | |
| 0.029 | 0.036 | 0.099 | Antidiuretic hormone antagonist | 0.099 0.013 CID_88638 | CID_88638 | |
| 0.067 | 0.075 | 0.168 | Acetylcholine nicotinic agonist | 0.168 0.012 CID_88638 | CID_88638 | |
| 0.03 | 0.039 | 0.072 | Somatostatin 4 agonist | 0.072 0.01 CID_88638 | CID_88638 | |
| 0.03 | 0.04 | 0.078 | Poly(ADP-ribose) polymerase 1 inhibitor | 0.078 0.009 CID_88638 | CID_88638 | |
| 0.019 | 0.03 | 0.062 | Vasopressin 1A antagonist | 0.062 0.011 CID_88638 | CID_88638 | |
| 0.026 | 0.04 | 0.036 | DNA topoisomerase IV inhibitor | 0.036 0.011 CID_88638 | CID_88638 | |
| 0.036 | 0.051 | 0.054 | Glutamate (mGluR4) antagonist | 0.054 0.017 CID_88638 | CID_88638 | |
| 0.052 | 0.067 | 0.072 | Phosphodiesterase 1A inhibitor | 0.072 0.022 CID_88638 | CID_88638 | |
| 0.023 | 0.038 | 0.029 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.029 0.013 CID_88638 | CID_88638 | |
| 0.021 | 0.037 | 0.052 | Vasopressin 1 antagonist | 0.052 0.014 CID_88638 | CID_88638 | |
| 0.041 | 0.057 | 0.099 | GABA A receptor antagonist | 0.099 0.016 CID_88638 | CID_88638 | |
| 0.016 | 0.033 | 0.025 | Glutaminyl-peptide cyclotransferase inhibitor | 0.025 0.01 CID_88638 | CID_88638 | |
| 0.017 | 0.039 | 0.058 | Poly(ADP-ribose) polymerase 2 inhibitor | 0.058 0.008 CID_88638 | CID_88638 | |
| 0.037 | 0.06 | 0.069 | Neuropeptide Y5 antagonist | 0.069 0.026 CID_88638 | CID_88638 | |
| 0.04 | 0.062 | 0.06 | Nicotinic alpha7 receptor agonist | 0.06 0.032 CID_88638 | CID_88638 | |
| 0.073 | 0.107 | 0.103 | Insulin receptor antagonist | 0.103 0.057 CID_88638 | CID_88638 | |
| 0.167 | 0.204 | 0.311 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.311 0.057 CID_88638 | CID_88638 | |
| 0.009 | 0.046 | 0.017 | Cathepsin S inhibitor | 0.017 0.015 CID_88638 | CID_88638 | |
| 0.05 | 0.087 | 0.098 | Protein kinase B alpha inhibitor | 0.098 0.031 CID_88638 | CID_88638 | |
| 0.185 | 0.222 | 0.364 | Histamine release inhibitor | 0.364 0.093 CID_88638 | CID_88638 | |
| 0.017 | 0.055 | 0.04 | Kainate receptor 2 antagonist | 0.04 0.022 CID_88638 | CID_88638 | |
| 0.056 | 0.095 | 0.099 | Acetylcholine nicotinic antagonist | 0.099 0.04 CID_88638 | CID_88638 | |
| 0.025 | 0.064 | 0.049 | Opioid kappa receptor agonist | 0.049 0.025 CID_88638 | CID_88638 | |
| 0.129 | 0.171 | 0.212 | Platelet antagonist | 0.212 0.093 CID_88638 | CID_88638 | |
| 0.031 | 0.074 | 0.117 | GABA B receptor antagonist | 0.117 0.004 CID_88638 | CID_88638 | |
| 0.032 | 0.075 | 0.094 | mTOR inhibitor | 0.094 0.013 CID_88638 | CID_88638 | |
| 0.042 | 0.091 | 0.09 | MAP kinase 11 inhibitor | 0.09 0.041 CID_88638 | CID_88638 | |
| 0.143 | 0.195 | 0.462 | 5 Hydroxytryptamine release stimulant | 0.462 0.034 CID_88638 | CID_88638 | |
| 0.04 | 0.094 | 0.053 | 5 Hydroxytryptamine 7 agonist | 0.053 0.046 CID_88638 | CID_88638 | |
| 0.082 | 0.137 | 0.106 | Acetylcholine release stimulant | 0.106 0.074 CID_88638 | CID_88638 | |
| 0.149 | 0.205 | 0.317 | DNA synthesis inhibitor | 0.317 0.038 CID_88638 | CID_88638 | |
| 0.031 | 0.087 | 0.088 | Nicotinic neuronal receptor agonist | 0.088 0.017 CID_88638 | CID_88638 | |
| 0.037 | 0.094 | 0.104 | Alpha 2 adrenoreceptor agonist | 0.104 0.013 CID_88638 | CID_88638 | |
| 0.029 | 0.09 | 0.08 | 5 Hydroxytryptamine 2 agonist | 0.08 0.015 CID_88638 | CID_88638 | |
| 0.065 | 0.128 | 0.115 | DNA directed RNA polymerase inhibitor | 0.115 0.041 CID_88638 | CID_88638 | |
| 0.025 | 0.094 | 0.043 | Nicotinic receptor alpha3 subunit antagonist | 0.043 0.031 CID_88638 | CID_88638 | |
| 0.015 | 0.085 | 0.149 | 5 Hydroxytryptamine 2C agonist | 0.149 0.005 CID_88638 | CID_88638 | |
| 0.025 | 0.095 | 0.056 | 5 Hydroxytryptamine 2B agonist | 0.056 0.01 CID_88638 | CID_88638 | |
| 0.136 | 0.215 | 0.179 | MAP kinase kinase 5 inhibitor | 0.179 0.065 CID_88638 | CID_88638 | |
| 0.034 | 0.113 | 0.077 | HIV-1 reverse transcriptase inhibitor | 0.077 0.044 CID_88638 | CID_88638 | |
| 0.017 | 0.1 | 0.036 | Oxytocin antagonist | 0.036 0.031 CID_88638 | CID_88638 | |
| 0.043 | 0.126 | 0.064 | Interferon inducer | 0.064 0.045 CID_88638 | CID_88638 | |
| 0.063 | 0.149 | 0.133 | Adenylate cyclase inhibitor | 0.133 0.057 CID_88638 | CID_88638 | |
| 0.043 | 0.132 | 0.062 | Phosphodiesterase 1C inhibitor | 0.062 0.044 CID_88638 | CID_88638 | |
| 0.026 | 0.119 | 0.095 | p38 MAP kinase inhibitor | 0.095 0.034 CID_88638 | CID_88638 | |
| 0.015 | 0.11 | 0.033 | 5 Hydroxytryptamine 6 agonist | 0.033 0.012 CID_88638 | CID_88638 | |
| 0.03 | 0.126 | 0.085 | Phosphodiesterase III inhibitor | 0.085 0.031 CID_88638 | CID_88638 | |
| 0.171 | 0.269 | 0.273 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.273 0.042 CID_88638 | CID_88638 | |
| 0.035 | 0.133 | 0.056 | Phosphodiesterase 1B inhibitor | 0.056 0.048 CID_88638 | CID_88638 | |
| 0.015 | 0.116 | 0.026 | Thymidine phosphorylase inhibitor | 0.026 0.017 CID_88638 | CID_88638 | |
| 0.046 | 0.148 | 0.075 | Phosphodiesterase VI inhibitor | 0.075 0.051 CID_88638 | CID_88638 | |
| 0.026 | 0.132 | 0.078 | 5 Hydroxytryptamine 2A agonist | 0.078 0.029 CID_88638 | CID_88638 | |
| 0.15 | 0.257 | 0.31 | Tyrosine 3 hydroxylase inhibitor | 0.31 0.029 CID_88638 | CID_88638 | |
| 0.013 | 0.121 | 0.026 | Acid ceramidase inhibitor | 0.026 0.016 CID_88638 | CID_88638 | |
| 0.051 | 0.159 | 0.123 | Prolactin inhibitor | 0.123 0.036 CID_88638 | CID_88638 | |
| 0.032 | 0.14 | 0.052 | Nicotinic alpha3beta2 receptor antagonist | 0.052 0.04 CID_88638 | CID_88638 | |
| 0.025 | 0.14 | 0.063 | Nicotinic receptor alpha4 subunit antagonist | 0.063 0.02 CID_88638 | CID_88638 | |
| 0.142 | 0.261 | 0.196 | 5 Hydroxytryptamine 3E antagonist | 0.196 0.07 CID_88638 | CID_88638 | |
| 0.042 | 0.162 | 0.074 | Interferon agonist | 0.074 0.062 CID_88638 | CID_88638 | |
| 0.022 | 0.142 | 0.059 | CDK4/cyclin D inhibitor | 0.059 0.04 CID_88638 | CID_88638 | |
| 0.155 | 0.275 | 0.325 | 5 Hydroxytryptamine uptake stimulant | 0.325 0.034 CID_88638 | CID_88638 | |
| 0.027 | 0.15 | 0.086 | Neuronal nicotinic receptor antagonist | 0.086 0.032 CID_88638 | CID_88638 | |
| 0.018 | 0.143 | 0.072 | NMDA 2C receptor antagonist | 0.072 0.031 CID_88638 | CID_88638 | |
| 0.019 | 0.148 | 0.032 | Protein kinase C beta I inhibitor | 0.032 0.028 CID_88638 | CID_88638 | |
| 0.014 | 0.149 | 0.059 | Dopamine D5 agonist | 0.059 0.012 CID_88638 | CID_88638 | |
| 0.053 | 0.189 | 0.134 | Phosphodiesterase 7B inhibitor | 0.134 0.028 CID_88638 | CID_88638 | |
| 0.022 | 0.159 | 0.064 | Nicotinic receptor alpha7 subunit antagonist | 0.064 0.025 CID_88638 | CID_88638 | |
| 0.108 | 0.246 | 0.155 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.155 0.125 CID_88638 | CID_88638 | |
| 0.09 | 0.239 | 0.14 | Interferon gamma antagonist | 0.14 0.093 CID_88638 | CID_88638 | |
| 0.132 | 0.282 | 0.214 | Antithrombotic | 0.214 0.161 CID_88638 | CID_88638 | |
| 0.051 | 0.205 | 0.177 | Protein kinase C zeta inhibitor | 0.177 0.015 CID_88638 | CID_88638 | |
| 0.058 | 0.213 | 0.193 | Toll-Like receptor 9 antagonist | 0.193 0.038 CID_88638 | CID_88638 | |
| 0.086 | 0.244 | 0.135 | Tumour necrosis factor antagonist | 0.135 0.12 CID_88638 | CID_88638 | |
| 0.019 | 0.178 | 0.049 | Phenylethanolamine N methyltransferase inhibitor | 0.049 0.015 CID_88638 | CID_88638 | |
| 0.011 | 0.169 | 0.031 | Epoxide hydrolase 1 inhibitor | 0.031 0.021 CID_88638 | CID_88638 | |
| 0.023 | 0.184 | 0.084 | Myc inhibitor | 0.084 0.012 CID_88638 | CID_88638 | |
| 0.047 | 0.21 | 0.097 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.097 0.057 CID_88638 | CID_88638 | |
| 0.078 | 0.248 | 0.185 | Polo-like kinase-3 inhibitor | 0.185 0.054 CID_88638 | CID_88638 | |
| 0.041 | 0.212 | 0.091 | Antineoplastic alkaloid | 0.091 0.054 CID_88638 | CID_88638 | |
| 0.01 | 0.181 | 0.05 | AMPA receptor antagonist | 0.05 0.031 CID_88638 | CID_88638 | |
| 0.019 | 0.191 | 0.091 | Cyclin-dependent kinase 6 inhibitor | 0.091 0.014 CID_88638 | CID_88638 | |
| 0.027 | 0.201 | 0.064 | DNA gyrase inhibitor | 0.064 0.043 CID_88638 | CID_88638 | |
| 0.09 | 0.264 | 0.188 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.188 0.087 CID_88638 | CID_88638 | |
| 0.087 | 0.262 | 0.141 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.141 0.091 CID_88638 | CID_88638 | |
| 0.022 | 0.198 | 0.057 | Androgen agonist | 0.057 0.046 CID_88638 | CID_88638 | |
| 0.01 | 0.197 | 0.048 | Phosphatidylinositol 3-kinase alpha inhibitor | 0.048 0.039 CID_88638 | CID_88638 | |
| 0.006 | 0.195 | 0.014 | Cyclin D2 inhibitor | 0.014 0.008 CID_88638 | CID_88638 | |
| 0.021 | 0.211 | 0.063 | CXC chemokine 4 receptor antagonist | 0.063 0.04 CID_88638 | CID_88638 | |
| 0.08 | 0.272 | 0.194 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.194 0.079 CID_88638 | CID_88638 | |
| 0.004 | 0.197 | 0.028 | Nicotinic alpha4 receptor agonist | 0.028 0.005 CID_88638 | CID_88638 | |
| 0.106 | 0.302 | 0.133 | Ca2+-transporting ATPase inhibitor | 0.133 0.103 CID_88638 | CID_88638 | |
| 0.071 | 0.272 | 0.165 | Interleukin agonist | 0.165 0.154 CID_88638 | CID_88638 | |
| 0.02 | 0.223 | 0.086 | Protein kinase C beta inhibitor | 0.086 0.023 CID_88638 | CID_88638 | |
| 0.159 | 0.364 | 0.298 | MAP kinase kinase 6 inhibitor | 0.298 0.137 CID_88638 | CID_88638 | |
| 0.074 | 0.287 | 0.114 | Vanilloid 1 agonist | 0.114 0.103 CID_88638 | CID_88638 | |
| 0.144 | 0.358 | 0.195 | MAP kinase kinase 3 inhibitor | 0.195 0.137 CID_88638 | CID_88638 | |
| 0.045 | 0.259 | 0.093 | mTOR complex 2 inhibitor | 0.093 0.042 CID_88638 | CID_88638 | |
| 0.043 | 0.258 | 0.145 | Bromodomain-containing protein 2 inhibitor | 0.145 0.01 CID_88638 | CID_88638 | |
| 0.061 | 0.276 | 0.234 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.234 0.054 CID_88638 | CID_88638 | |
| 0.068 | 0.285 | 0.103 | Interleukin 2 antagonist | 0.103 0.081 CID_88638 | CID_88638 | |
| 0.041 | 0.26 | 0.091 | AMP-activated protein kinase stimulant | 0.091 0.084 CID_88638 | CID_88638 | |
| 0.005 | 0.225 | 0.044 | Nicotinic alpha4beta2 receptor agonist | 0.044 0.006 CID_88638 | CID_88638 | |
| 0.017 | 0.24 | 0.071 | Benzodiazepine agonist | 0.071 0.05 CID_88638 | CID_88638 | |
| 0.015 | 0.246 | 0.06 | CDK4/cyclin D1 inhibitor | 0.06 0.039 CID_88638 | CID_88638 | |
| 0.012 | 0.244 | 0.045 | Bromodomain-containing protein 3 inhibitor | 0.045 0.042 CID_88638 | CID_88638 | |
| 0.015 | 0.248 | 0.039 | ATR kinase inhibitor | 0.039 0.013 CID_88638 | CID_88638 | |
| 0.16 | 0.393 | 0.347 | Caspase 9 stimulant | 0.347 0.148 CID_88638 | CID_88638 | |
| 0.103 | 0.349 | 0.273 | RNA-directed DNA polymerase inhibitor | 0.273 0.039 CID_88638 | CID_88638 | |
| 0.025 | 0.271 | 0.095 | ALK inhibitor | 0.095 0.044 CID_88638 | CID_88638 | |
| 0.026 | 0.281 | 0.066 | Corticotropin releasing factor 2 receptor antagonist | 0.066 0.034 CID_88638 | CID_88638 | |
| 0.005 | 0.261 | 0.043 | Nicotinic alpha3beta4 receptor agonist | 0.043 0.008 CID_88638 | CID_88638 | |
| 0.007 | 0.27 | 0.046 | Guanylate cyclase inhibitor | 0.046 0.025 CID_88638 | CID_88638 | |
| 0.032 | 0.304 | 0.085 | Polo-like kinase-1 inhibitor | 0.085 0.072 CID_88638 | CID_88638 | |
| 0.088 | 0.364 | 0.248 | Gastrin inhibitor | 0.248 0.082 CID_88638 | CID_88638 | |
| 0.024 | 0.303 | 0.097 | Pim-3 kinase inhibitor | 0.097 0.048 CID_88638 | CID_88638 | |
| 0.032 | 0.313 | 0.144 | Protein kinase C gamma inhibitor | 0.144 0.035 CID_88638 | CID_88638 | |
| 0.08 | 0.363 | 0.252 | Superoxide dismutase inhibitor | 0.252 0.073 CID_88638 | CID_88638 | |
| 0.038 | 0.323 | 0.089 | MAP kinase kinase 7 inhibitor | 0.089 0.027 CID_88638 | CID_88638 | |
| 0.034 | 0.321 | 0.089 | MAP kinase kinase 1 inhibitor | 0.089 0.072 CID_88638 | CID_88638 | |
| 0.02 | 0.308 | 0.058 | Topoisomerase II beta inhibitor | 0.058 0.024 CID_88638 | CID_88638 | |
| 0.027 | 0.317 | 0.056 | Ryanodine receptor antagonist | 0.056 0.05 CID_88638 | CID_88638 | |
| 0.029 | 0.327 | 0.261 | GABA C receptor agonist | 0.261 0.012 CID_88638 | CID_88638 | |
| 0.106 | 0.405 | 0.166 | Nitric-oxide synthase stimulant | 0.166 0.163 CID_88638 | CID_88638 | |
| 0.016 | 0.319 | 0.055 | Purinergic P2X4 antagonist | 0.055 0.019 CID_88638 | CID_88638 | |
| 0.01 | 0.323 | 0.055 | Argininosuccinate synthase inhibitor | 0.055 0.042 CID_88638 | CID_88638 | |
| 0.012 | 0.329 | 0.055 | Carbamoyl phosphate synthetase inhibitor | 0.055 0.049 CID_88638 | CID_88638 | |
| 0.043 | 0.363 | 0.197 | MAP kinase kinase 2 inhibitor | 0.197 0.084 CID_88638 | CID_88638 | |
| 0.032 | 0.359 | 0.123 | Cytidine deaminase inhibitor | 0.123 0.098 CID_88638 | CID_88638 | |
| 0.08 | 0.407 | 0.139 | Neurotensin receptor agonist | 0.139 0.131 CID_88638 | CID_88638 | |
| 0.012 | 0.352 | 0.064 | CDC7 inhibitor | 0.064 0.051 CID_88638 | CID_88638 | |
| 0.025 | 0.387 | 0.117 | UDP-glucose 4-epimerase inhibitor | 0.117 0.045 CID_88638 | CID_88638 | |
| 0.025 | 0.391 | 0.124 | Ribosomal protein S6 kinase inhibitor | 0.124 0.086 CID_88638 | CID_88638 | |
| 0.026 | 0.409 | 0.089 | HIV-1 integrase (Overall Integration) inhibitor | 0.089 0.066 CID_88638 | CID_88638 | |
| 0.01 | 0.393 | 0.107 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.107 0.032 CID_88638 | CID_88638 | |
| 0.07 | 0.458 | 0.176 | MAP-kinase-activated kinase 5 inhibitor | 0.176 0.137 CID_88638 | CID_88638 | |
| 0.037 | 0.428 | 0.176 | Cyclin-dependent kinase 8 inhibitor | 0.176 0.055 CID_88638 | CID_88638 | |
| 0.032 | 0.43 | 0.138 | Activin receptor-like kinase 2 inhibitor | 0.138 0.077 CID_88638 | CID_88638 | |
| 0.023 | 0.427 | 0.074 | Glycine receptor agonist | 0.074 0.048 CID_88638 | CID_88638 | |
| 0.026 | 0.431 | 0.168 | Alpha-N-acetylglucosaminidase inhibitor | 0.168 0.046 CID_88638 | CID_88638 | |
| 0.009 | 0.415 | 0.089 | Check point kinase 1 inhibitor | 0.089 0.033 CID_88638 | CID_88638 | |
| 0.01 | 0.418 | 0.107 | Check point kinase 2 inhibitor | 0.107 0.059 CID_88638 | CID_88638 | |
| 0.115 | 0.535 | 0.235 | Calcium channel L-type activator | 0.235 0.222 CID_88638 | CID_88638 | |
| 0.008 | 0.431 | 0.062 | Cyclin A1 inhibitor | 0.062 0.034 CID_88638 | CID_88638 | |
| 0.007 | 0.429 | 0.057 | NMDA receptor glycine site agonist | 0.057 0.049 CID_88638 | CID_88638 | |
| 0.075 | 0.516 | 0.293 | GABA C receptor rho-3 antagonist | 0.293 0.121 CID_88638 | CID_88638 | |
| 0.009 | 0.458 | 0.054 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.054 0.042 CID_88638 | CID_88638 | |
| 0.012 | 0.462 | 0.058 | NMDA receptor agonist | 0.058 0.051 CID_88638 | CID_88638 | |
| 0.006 | 0.459 | 0.082 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.082 0.068 CID_88638 | CID_88638 | |
| 0.017 | 0.479 | 0.15 | GABA C receptor antagonist | 0.15 0.03 CID_88638 | CID_88638 | |
| 0.021 | 0.484 | 0.151 | GABA C receptor rho-1 antagonist | 0.151 0.021 CID_88638 | CID_88638 | |
| 0.026 | 0.508 | 0.079 | NADH dehydrogenase inhibitor | 0.079 0.077 CID_88638 | CID_88638 | |
| 0.039 | 0.528 | 0.174 | Focal adhesion kinase 2 inhibitor | 0.174 0.095 CID_88638 | CID_88638 | |
| 0.059 | 0.553 | 0.219 | Insulysin inhibitor | 0.219 0.13 CID_88638 | CID_88638 | |
| 0.019 | 0.537 | 0.157 | I kappa B kinase epsilon inhibitor | 0.157 0.112 CID_88638 | CID_88638 | |
| 0.033 | 0.552 | 0.149 | GABA C receptor rho-2 antagonist | 0.149 0.075 CID_88638 | CID_88638 | |
| 0.033 | 0.553 | 0.128 | Adenylate cyclase stimulant | 0.128 0.107 CID_88638 | CID_88638 | |
| 0.025 | 0.582 | 0.119 | Hemostatic | 0.119 0.116 CID_88638 | CID_88638 | |
| 0.01 | 0.596 | 0.066 | MAP-kinase-activated kinase 2 inhibitor | 0.066 0.065 CID_88638 | CID_88638 | |
| 0.013 | 0.609 | 0.076 | MAP-kinase-activated kinase inhibitor | 0.076 0.069 CID_88638 | CID_88638 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |